Interferon as a Defence Mechanism in Mouse Cytomegalovirus Infection

References

1. Bancroft G. J., Shellam G. R., Grundy Chalmer J. E. 1981; Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. Journal of Immunology 126:988–995
   [Google Scholar]
2. Chong K. T., Gould J. J., Mims C. A. 1981; Neutralization of different strains of murine cytomegalovirus (MCMV) - effect of in vitro passage. Archives of Virology 69:95–104
   [Google Scholar]
3. Gidlund M., Orn A., Wigzell H., Senik A., Gresser I. 1978; Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature, London 273:759–761
   [Google Scholar]
4. Gresser I., Tovey M. G., Bandu M. T., Maury C., Brouty-Boye D. 1976a; Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. Journal of Experimental Medicine 144:1305–1315
   [Google Scholar]
5. Gresser I., Tovey M. G., Maury C., Bandu M.T. 1976b; Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. Journal of Experimental Medicine 144:1316
   [Google Scholar]
6. Grundy Chalme J. E., Trapman J., Allan J. E., Shellam G. R., Melief C. J. M. 1982; Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infection and Immunity 37:143–150
   [Google Scholar]
7. Herberman R. B., Ortaldo J. R., Bonnard G. D. 1979; Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature, London 277:221–223
   [Google Scholar]
8. Kern E. R., Olsen G. A., Overall J. C., Glasgow L. A. 1978; Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid and polyinosinic-polycytidylic acid – poly-l-lysine complex. Antimicrobial Agents and Chemotherapy 13:344–346
   [Google Scholar]
9. Mims C. A., Gould J. 1978; Splenic necrosis in mice infected with cytomegalovirus. Journal of Infectious Diseases 137:587–591
   [Google Scholar]
10. Oie H. K., Easton J. M., Ablashi D. V., Baron S. 1975; Murine cytomegalovirus. Induction of and sensitivity to interferon in vitro. Infection and Immunity 11:1012–1017
    [Google Scholar]
11. Osborn J. E., Medearis D. N. 1966; Studies of relationship between mouse cytomegalovirus and interferon. Proceedings of the Society for Experimental Biology and Medicine 121:819–824
    [Google Scholar]
12. Quinnan G. V., Manischewitz J. F., Kirmani N. 1982; Involvement of natural killer cells in the pathogenesis of murine cytomegalovirus interstitial pneumonitis and the immune response to infection. Journal of General Virology 58:173–180
    [Google Scholar]
13. Shellam G. R., Allan J. E., Papadimitriou J. M., Bancroft G. J. 1981; Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proceedings of the National Academy of Sciences of the United States of America 78:5104–5108
    [Google Scholar]
14. Tarr G. C., Armstrong J. A., Ho M. 1978; Production of interferon and serum hyporeactivity factor in mice infected with murine cytomegalovirus. Infection and Immunity 19:903–907
    [Google Scholar]
15. Trinchieri G., Santoli D., Koprowski H. 1978; Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immuno-globulins. Journal of Immunology 120:1849–1855
    [Google Scholar]
16. Virelizier J. L., Gresser I. 1978; Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3. Infection of susceptible and resistant strains of mice. Journal of Immunology 120:1616–1619
    [Google Scholar]